Federal regulators will allow Emergent Biosolutions to resume production of the Johnson & Johnson COVID-19 vaccine after production woes, officials said Thursday.
↧
Federal regulators will allow Emergent Biosolutions to resume production of the Johnson & Johnson COVID-19 vaccine after production woes, officials said Thursday.